Costello Asset Management, Inc Abb Vie Inc. Transaction History

Costello Asset Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $5,300 - $6,596	-40 Reduced 40.0%	60 $8,000
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $8,578 - $10,643	65 Added 185.71%	100 $16,000
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $18,907 - $23,923	-176 Reduced 83.41%	35 $5,000
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $3,192 - $3,623	30 Added 16.57%	211 $23,000
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $105 - $117	1 Added 0.56%	181 $20,000
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $2,659 - $2,928	26 Added 16.88%	180 $20,000
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $160 - $217	2 Added 1.32%	154 $16,000
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $171 - $201	2 Added 1.33%	152 $13,000
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $11,005 - $14,727	150 New	150 $15,000

3,995

1.29B

18.2M

13.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Costello Asset Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Costello Asset Management, Inc with notifications on news.